• Existing Student?   Click Here to Login
IfappAcademy.org
  • WELCOME TOIFAPP ACADEMY
    • WELCOME
    • STRATEGIC ALLIANCE KING’S COLLEGE LONDON
    • VALUE OF CERTIFICATION
    • VALUE OF MEDICAL AFFAIRS
    • HOT TOPICS OF MEDICAL AFFAIRS
  • WHY MEDICALAFFAIRS
    • CORE CAPABILITIES
    • COMPETENCIES
    • WHATS NEW IN MEDICAL AFFAIRS
  • PROSPECTIVESTUDENTS
    • REQUIREMENTS
    • BENEFITS
    • CERTIFICATION, ACCREDITATION, & CREDENTIALING
    • 2021 PROGRAM INFORMATION & APPLICATION
  • PROGRAM
    • PROGRAM DETAILS
    • TIMELINES
    • LEARNING OUTCOMES
  • ABOUT US
    • NEWS FROM IFAPP ACADEMY
    • BOARD OF OFFICERS
    • ADVISORY COUNCIL
    • FACULTY
  • CONTACT US
  • Search
  • Menu Menu
  • Facebook
  • LinkedIn
  • Youtube
  • WELCOME TOIFAPP ACADEMY
    • WELCOME
    • STRATEGIC ALLIANCE KING’S COLLEGE LONDON
    • VALUE OF CERTIFICATION
    • VALUE OF MEDICAL AFFAIRS
    • HOT TOPICS OF MEDICAL AFFAIRS
  • WHY MEDICALAFFAIRS
    • CORE CAPABILITIES
    • COMPETENCIES
    • WHATS NEW IN MEDICAL AFFAIRS
  • PROSPECTIVESTUDENTS
    • REQUIREMENTS
    • BENEFITS
    • CERTIFICATION, ACCREDITATION, & CREDENTIALING
    • 2021 PROGRAM INFORMATION & APPLICATION
  • PROGRAM
    • PROGRAM DETAILS
    • TIMELINES
    • LEARNING OUTCOMES
  • ABOUT US
    • NEWS FROM IFAPP ACADEMY
    • BOARD OF OFFICERS
    • ADVISORY COUNCIL
    • FACULTY
  • CONTACT US
You are here: Home1 / John Alter – Faculty – IFAPP Academy
IFAPP Academy Faculty, John Alter

John Alter

John is currently Vice President, Global Health and Value for Pfizer’s Essential Health business unit, which has worldwide sales of more than $20B from a portfolio of over 700 molecules including biosimilars, sterile injectables and solid oral dosage forms. The portfolio is the result of Pfizer’s research and development as well as from the acquisitions of Warner Lambert, Pharmacia and Upjohn, Wyeth and most recently Hospira. Pfizer is the world’s leading biosimilars company based on audited sales and its portfolio of biosimilar molecules is for the treatment of inflammation, oncology and supportive care.

Pfizer’s Global Health and Value team covers the functions of Pricing, Access, Reimbursement, Health Economics, Outcomes Research and Real World Data.  John has been with Pfizer for over 18 years in multiple roles of increasing responsibilities, the last three years in his current role.  He has presented at several conferences on the topic of pricing, access and health economics.

Faculty Member

  • Ahmed Shelbaya
  • Ana B Salgado
  • Beate Schmidt
  • Bill Lam
  • Brenda Raphael
  • Carl Naraynassamy
  • Christine Carberry
  • Christopher Paul Milne
  • Daniel Garcia
  • David Morgan
  • Domenico Criscuolo
  • Dominique Dubois
  • Edward Power
  • Greg Koski
  • Helene Schluep
  • Jacqui Piner
  • Jeffrey Cohen
  • Jeff Duke
  • John Alter
  • Juliana Hey-Hadavi
  • Kamlesh Thakker
  • Kenneth Kaitin
  • Laurent Pacheco
  • Larry Kennedy
  • Lisa Egbuonu-Davis
  • Mike Collins
  • Nikolas Karkanias
  • Omar Antonio Alvarez-Pousa
  • Paula Tully
  • Peter Sajben
  • Petra Dörr
  • Pol Vandenbroucke
  • Pravin Chopra
  • Rory O’Connor
  • Sandor Kerpel-Fronius
  • Seema Haider
  • Shayesteh Fürst-Ladani
  • Soneil Guptha
  • Susy Davis
  • Syed Kazmi
  • Tamás Sütő
  • Tony W. Fox
  • Xavier Luria
  • Zaide Frias
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).

 Site Map | Contact Us |Privacy Policy | Cookies
© Copyright - IfappAcademy.org - powered by Enfold WordPress Theme
  • Facebook
  • LinkedIn
  • Youtube
Scroll to top